{"id":1682,"date":"2023-10-16T04:59:34","date_gmt":"2023-10-16T11:59:34","guid":{"rendered":"https:\/\/alivamab.com\/staging\/?p=1682"},"modified":"2023-10-16T05:21:52","modified_gmt":"2023-10-16T12:21:52","slug":"alivamab-discovery-services-changes-name-to-alivamab-biologics-reflecting-its-continuing-expansion-and-evolution","status":"publish","type":"post","link":"https:\/\/alivamab.com\/staging\/news\/alivamab-discovery-services-changes-name-to-alivamab-biologics-reflecting-its-continuing-expansion-and-evolution\/","title":{"rendered":"AlivaMab Discovery Services Changes Name to AlivaMab Biologics, Reflecting Its Continuing Expansion and Evolution"},"content":{"rendered":"

Launching new and expanded capabilities providing end-to-end solutions in biologics discovery and engineering<\/strong> <\/em><\/h2>\n

SAN DIEGO, Calif. \u2013 October 16, 2023 \u2013\u00a0AlivaMab Discovery Services, LLC\u00a0(\u201cADS\u201d), a leader in the discovery of superior biologic drugs, today announced its new corporate identity as AlivaMab Biologics, LLC (\u201cAMB\u201d). With this name change, AlivaMab Biologics unveils a new logo, plus upcoming events that include a new website and a move to a modern, new facility in San Diego. Catalyzing this rebranding are new breadth and depth of capabilities in biologics drug discovery, led by a refreshed leadership team of diverse experiences and backgrounds, altogether expanding the corporate vision.<\/p>\n

\u201cWe are now AlivaMab Biologics because the company has grown and evolved beyond its 2018 founding mission of providing therapeutic antibody generation services,\u201d said Larry Green, Chief Executive Officer at AlivaMab Biologics. \u201cWhile therapeutic antibody discovery using AlivaMab\u00ae Mouse and multispecific engineering remains a core part of our business, we have quietly been delivering much more than that for our clients, as the AMB team brings the experience, intellect, and integrity that together with our platform capabilities can enable fully integrated biologics drug discovery for our partners. We look forward to announcing further details in the coming months on our new platforms and capabilities in providing end-to-end solutions in biologics drug discovery.\u201d<\/p>\n

About AlivaMab Biologics<\/strong><\/p>\n

AlivaMab Biologics provides fully integrated solutions for biologics drug discovery through our expanding platform of innovative capability modules. AMB\u2019s customizable capability modules include target validation, protein- and cell-based tool engineering and production, sophisticated functional assay development and execution, discovery of binding domains using Ablexis\u2019 family of AlivaMab Mouse strains, kinetic and epitope characterization, protein and antibody engineering across a breadth of novel biologic drug modalities, full-depth developability assessment, antibody optimization, and production up to medium scale. AMB\u2019s partners also gain from the team\u2019s direct experience and know-how in the discovery and development of biologics drugs across various modalities. Partners may select to work with AMB across the full spectrum of capability modules or to pick and choose across them. AlivaMab Biologics sets its partners\u2019 biologics programs on the path to success with the fastest and most de-risked solutions through discovery and development.<\/p>\n

For more information, please visit www.alivamab.com<\/a> or email info@alivamab.com<\/a>.<\/p>\n

 <\/p>\n

BD Contact:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Media Contact:
\n<\/strong>Matthew Beaulieu\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Maya Tanaka
\nmbeaulieu@alivamab.com<\/a>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0mtanaka@alivamab.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Launching new and expanded capabilities providing end-to-end solutions in biologics discovery and engineering SAN DIEGO, Calif. \u2013 October 16, 2023 \u2013\u00a0AlivaMab Discovery Services, LLC\u00a0(\u201cADS\u201d), a leader in the discovery of superior biologic drugs, today announced its new corporate identity as AlivaMab Biologics, LLC (\u201cAMB\u201d). With this name change, AlivaMab Biologics unveils a new logo, plus […]<\/p>\n","protected":false},"author":2,"featured_media":1696,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"_links":{"self":[{"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/posts\/1682"}],"collection":[{"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/comments?post=1682"}],"version-history":[{"count":1,"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/posts\/1682\/revisions"}],"predecessor-version":[{"id":1683,"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/posts\/1682\/revisions\/1683"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/media\/1696"}],"wp:attachment":[{"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/media?parent=1682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/categories?post=1682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alivamab.com\/staging\/wp-json\/wp\/v2\/tags?post=1682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}